Skip to content

„Limited Options with Extended Resistance to antiretroviral therapy: A National Survey of Triple Class Resistance”

„Limited Options with Extended Resistance to antiretroviral therapy: A National Survey of Triple Class Resistance” - LOWER

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00012396
Enrollment
250
Registered
2017-06-09
Start date
2017-04-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B24

Interventions

Group 1: Single arm. Interventions: Questionnaires for patients and treating physicians. Collection of 10 mL EDTA blood (during routine checks) for resistance analysis

Sponsors

ICH Study Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Documented HIV-infection, age of at least 18 years, documented triple-class-resistance (NRTIs, NNRTIs, PIs or INSTIs), documented by at least one resistance test), written informed consent

Exclusion criteria

Exclusion criteria: No documented triple-class resistance, medical illness that does not allow safe blood draw, age under 18 years, cognitive impairment leading to inability to fill out the questionnaires and/or to give informed assent or consent.

Design outcomes

Primary

MeasureTime frame
Concordance between current resistance analysis (evaluated by ultra deep sequencing from proviral DNA) and prior resistance pattern (historical test results)

Secondary

MeasureTime frame
Current antiretroviral therapy, remaining options. Virological and immunological situation. Physical and mental health of the patients. Adherence and treatment satisfaction with current antiretroviral therapy (evaluated by questionnaires)

Countries

Germany

Contacts

Public ContactChristian Hoffmann

Infektionsmedizinisches Centrum Hamburg, ICH Study Center

hoffmann@ich-hamburg.de+49 (0)40 284073-70

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026